|
|
| Maladies Digestives > Etude de marché sectorielle |
|
|
|
|
€ 2 308,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2005 |
Taille du document : |
403 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
OTC Digestive Remedies in Germany
15 pages | Juillet 2002 |
The German market for OTC digestive remedies totaled Euro 446.9 million (US$421.9 million) in 2001, an increase of nearly 1% on the previous year and they remain important with a 11% share of all self |
198,00 €
|
| |
| |
US Gastrointestinal Remedies 2004
12 pages | Novembre 2004 |
Snapdata's US Gastrointestinal Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US gastrointestinal |
240,00 €
|
| |
| |
Healthy Eating - Spain
83 pages | Août 2006 |
About this reportThis report examines eating habits in terms of the level to which consumers are choosing healthy eating options, such as sugar-free, low-fat, functional and fortified products, as wel |
535,00 €
|
| |
| |
Stakeholder Insight: Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged
259 pages | Décembre 2004 |
IntroductionPancreatic adenocarcinoma is the fifth leading cancer-related cause of death and is thus a major health issue in the developed world.
Its aggressive nature and resistance to conventiona |
12 160,00 €
|
| |
| |
U.S. Point of Care Glucose Testing Market, 1997-2007
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
PROactive Results - The Diabetes Trial That Could Have Been
40 pages | Novembre 2005 |
IntroductionThe socio-economic consequences of diabetes and its complications make it a major public health issue.
Patients with diabetes have a 25% reduction in life expectancy compared with the g |
3 230,00 €
|
| |
| |
UK Digestive Remedies 2004
14 pages | Juillet 2004 |
Snapdata's UK Digestive Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK digestive remedy market, |
240,00 €
|
| |
| |
US Laxatives 2005
14 pages | Juin 2005 |
Snapdata's US Laxatives 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US laxative market, and covers laxat |
240,00 €
|
| |
| |
Antiulcerants Class Growth, 1991-2010
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
US Laxatives 2004
12 pages | Novembre 2004 |
Snapdata's US Laxatives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US laxative market, and covers laxat |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
This report analyzes the worldwide markets for Diabetes Diagnostics in Thousands of US$. The major product segments analyzed are Blood Glucose Testing Devices, and Diabetes Testing Supplies. The sub product segments analyzed include Blood Glucose Test Kit, Blood Glucose Monitor, Diabetes Kit, Diabetes Tracking System, Blood Glucose Sensor, Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, Blood Glucose Insta Glucose, Control Solution, Glutose, and Reagent Tablet. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 73 companies including many key and niche players worldwide such as Abbott Diabetes Care, Aventis Pharma Limited, Bayer HealthCare Diabates Care Division, Bio-Rad Laboratories, BioSignia, Inc., Celera Diagnostics, Cholestech Corporation, Eli Lilly and Company (India) Pvt. Ltd., Home Diagnostics, Inc., LifeScan, Inc., Medtronic MiniMed, Metrika, Inc., Novo Nordisk A/S, Quest Diagnostics, Roche Diagnostics and Sanwa Kagaku Kenkyusho co.Ltd.
|
|
|
PPLSEN
|
|
|
|
|
